비스테로이드소염제 관련 소화성궤양의 예방과 치료 가이드라인
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이준행 | - |
dc.contributor.author | 이용찬 | - |
dc.contributor.author | 전성우 | - |
dc.contributor.author | 김정욱 | - |
dc.contributor.author | 이상우 | - |
dc.contributor.author | 대한 Helicobacter 및 상부위장관 연구학회 | - |
dc.contributor.author | 대한소화기학회 | - |
dc.date.available | 2020-11-03T07:46:45Z | - |
dc.date.created | 2020-10-19 | - |
dc.date.issued | 2009-11 | - |
dc.identifier.issn | 1598-9992 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/15665 | - |
dc.description.abstract | Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used medications in Korea. Gastrointestinal toxicity, including peptic ulcer, is a common adverse effect of NSAIDs. Risk factors for NSAID-related peptic ulcer include a previous history of peptic ulcer, advanced age, high dose, concomitant use of corticosteroids, anticoagulants, other NSAIDs including low-dose aspirin. Preventive measure(s), such as COX-2 inhibitor, proton pump inhibitor or misoprostrol, should be done for patients requiring NSAID therapy who have high-risk factor(s) for peptic ulcer. Low dose aspirin also increases the risk of peptic ulcer, so preventive measure(s) should be done for high-risk patients. The eradication of Helicobacter pylori is recommended for high-risk NSAID-users. Treatment strategies for peptic ulcers in NSAID users are mostly the same for peptic ulcers in NSAID non-users. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한소화기학회 | - |
dc.title | 비스테로이드소염제 관련 소화성궤양의 예방과 치료 가이드라인 | - |
dc.title.alternative | Guidelines of Prevention and Treatment for NSAID-related Peptic Ulcers | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 이상우 | - |
dc.identifier.doi | 10.4166/kjg.2009.54.5.309 | - |
dc.identifier.scopusid | 2-s2.0-75349103200 | - |
dc.identifier.bibliographicCitation | The Korean Journal of Gastroenterology, v.54, no.5, pp.309 - 317 | - |
dc.relation.isPartOf | The Korean Journal of Gastroenterology | - |
dc.citation.title | The Korean Journal of Gastroenterology | - |
dc.citation.volume | 54 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 309 | - |
dc.citation.endPage | 317 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001392299 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Non-steroidal anti-inflammatory drug | - |
dc.subject.keywordAuthor | Peptic ulcer | - |
dc.subject.keywordAuthor | Prevention | - |
dc.subject.keywordAuthor | Guideline | - |
dc.identifier.url | https://www.kjg.or.kr/journal/view.html?uid=4147&vmd=Full | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.